| Literature DB >> 25518019 |
Ersin Gürkan Dumlu1, Mehmet Tokaç1, Birkan Bozkurt1, Murat Baki Yildirim1, Merve Ergin2, Abdussamed Yalçin3, Mehmet Kiliç3.
Abstract
OBJECTIVES: To determine the serum and tissue levels of markers of impaired oxidative metabolism and correlate these levels with the histopathology and Alvarado score of acute appendicitis patients.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25518019 PMCID: PMC4221314 DOI: 10.6061/clinics/2014(10)05
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Alvarado score for appendicitis 4.
| Score | |
| Migratory right iliac fossa pain | 1 |
| Nausea/vomiting | 1 |
| Anorexia | 1 |
| Tenderness in the right iliac fossa | 2 |
| Rebound tenderness in the right iliac fossa | 1 |
| Elevated temperature | 1 |
| Leukocytosis | 1 |
| Neutrophil shift to the left | 1 |
| 10 |
Demographic and clinical characteristics of patients with according to their pathological diagnosis.
| No appendicitis (negative) | Acute appendicitis | Perforated appendicitis | Phlegmonous appendicitis | Perforated+phlegmonous appendicitis | ||
| n | 4 | 37 | 8 | 12 | 4 | |
| Age (years) | 30.5±11.1 | 32.06±10.47 | 34.88±15.74 | 25.92±6.49 | 33.5±9.82 | 0.371 |
| Gender (male/female) | 1/3 (25/75) | 15/22 (40.5/59.5) | 5/3 (62.5/37.5) | 8/4 (66.7/33.3) | 1/3 (25/75) | 0.352 |
| Surgical technique (open/laparoscopic) | 4/0 (100/0) | 34/3 (91.9/8.1) | 8/0 (100/0) | 12/0 (100/0) | 3/1 (75/25) | 0.419 |
| US evaluation (no/yes) | 4/0 (100/0) | 30/7 (81.1/18.9) | 8/0 (100/0) | 9/3 (75/25) | 2/2 (50/50) | 0.234 |
| CT (not performed/performed) | 4/0 (100/0) | 35/2 (94.6/5.4) | 3/5 (37.5/62.5) | 11/1 (91.7/8.3) | 1/3 (25/75) | <0.001 |
| Alvarado score | 5.5±2.52 | 5.82±1.58 | 6.38±1.69 | 7.25±1.55 | 9±1.16 | 0.002 |
| Hospitalization duration | 1.25±0.5 | 1.28±0.87 | 3.38±1.99 | 1.75±1.14 | 5±1.41 | <0.001 |
| Leukocytes (K/μL) | 9650±2145.54 | 12021.63±4751.62 | 12737.5±3601.17 | 11583.34±4683.41 | 14475±8109.82 | 0.674 |
The hospitalization durations of patients without appendicitis and pathologically diagnosed acute appendicitis were significantly shorter than those of the perforated and perforated+phlegmonous appendicitis groups (p = 0.025 and p<0.001 for no appendicitis; p<0.001 for appendicitis, respectively). The duration of hospitalization was significantly longer in perforated+phlegmonous appendicitis group than in the phlegmonous appendicitis group (p<0.001), while it was longer in the perforated appendicitis group than in the phlegmonous appendicitis group (p = 0.020).
Levels of serum parameters in control subjects and appendectomized patients.
| Control (n = 30) | Appendectomized subjects | |||||
| Preoperative (Pre) | Postoperative (Post) | Pre | Pre | Post vs. Control | ||
| TAS (mmol Trolox Eq/L) | 2.28±0.24 | 2.08±0.25 | 2.05±0.27 | 0.590 | ||
| TOS (μmol H2O2 Eq/L) | 3.15±1.4 | 5.89±4.8 | 5.23±3.78 | 0.593 | ||
| Paraoxonase (U/L) | 208.98±100.13 | 199.09±114.18 | 188.2±116.8 | 0.111 | 0.838 | 0.467 |
| Stimulated paraoxonase (U/L) | 589.25±309.88 | 561.85±346.97 | 528.88±354.26 | 0.160 | 0.854 | 0.526 |
| Arylesterase (KU/L) | 234.53±50.15 | 197.53±55.81 | 194.42±50.03 | 0.096 | 0.176 | |
| Ceruloplasmin (U/L) | 17.57±6.74 | 14.76±6.42 | 14.62±6.93 | 0.535 | 0.056 | 0.088 |
| Catalase (U/L) | 104.03±82.4 | 252.38±170.65 | 229.33±158.44 | 0.583 | ||
| TTL (μmol/L) | 260.8±54.3 | 177.61±38.82 | 181.6±38.72 | 0.951 | ||
| Myeloperoxidase (U/L) | 111.64±40.21 | 136.73±49.98 | 137.59±48.4 | 0.826 | 0.080 | 0.057 |
| AOPP (μmol chloramine-T Eq/L) | 136.39±163.7 | 53.29±24.24 | 47.86±24.24 | 0.039 | ||
| IMA (absorbance unit, ABSU) | 0.31±0.09 | 0.64±0.09 | 0.66±0.08 | 0.197 | ||
Levels of serum parameters with respect to pathological diagnosis.
| No appendicitis (negative) | Acute appendicitis | Perforated appendicitis | Phlegmonous appendicitis | Perforated+phlegmonous appendicitis | ||
| TAS (mmol Trolox Eq/L) | 2.16±0.13 | 2.06±0.26 | 2.07±0.3 | 2.05±0.26 | 1.99±0.28 | 0.738 |
| TOS (μmol H2O2 Eq/L) | 4.22±1.37 | 4.82±3.03 | 8.74±6.21 | 5.67±4.9 | 7.16±7.11 | |
| Paraoxonase (U/L) | 227.24±99.47 | 197.34±133.32 | 169.26±87.54 | 175.93±74.87 | 227.73±95.89 | 0.608 |
| Stimulated paraoxonase (U/L) | 650.47±297.46 | 556.19±405.37 | 470.52±268.69 | 496.6±229.5 | 636.15±281.06 | 0.645 |
| Arylesterase (KU/L) | 214.69±48.26 | 196.5±51.76 | 193.78±49.76 | 182.81±61.03 | 216.3±45.98 | 0.451 |
| Ceruloplasmin (U/L) | 13.15±3.87 | 15.11±6.87 | 14.19±4.96 | 13.93±7.23 | 15.6±8.68 | 0.868 |
| Catalase (U/L) | 193.02±103.15 | 211.09±145.06 | 361.04±191 | 262.41±157.84 | 258.97±247.33 | |
| TTL (μmol/L) | 194.34±39.01 | 182.26±36.63 | 155.59±23.89 | 182.75±44.26 | 178.94±52.07 | 0.095 |
| Myeloperoxidase (U/L) | 152.62±34.76 | 139.77±44.35 | 136.34±69.76 | 137.73±47.55 | 97.45±50.33 | 0.18 |
| AOPP (μmol chloramine-T Eq/L) | 47.33±12.51 | 46.66±20.78 | 66.45±31.25 | 51.48±26.25 | 55.56±32.93 | 0.052 |
| IMA (absorbance unit, ABSU) | 0.65±0.09 | 0.64±0.09 | 0.67±0.09 | 0.67±0.09 | 0.67±0.1 | 0.337 |
Levels of tissue parameters with respect to the pathological diagnosis.
| No appendicitis (negative) | Acute appendicitis | Perforated appendicitis | Phlegmonous appendicitis | Perforated+phlegmonous appendicitis | ||
| Protein level with the Lowry method (mg/mL) | 1.87±1.9 | 2.88±1.25 | 2.63±1.87 | 3.19±1.72 | 3.22±0.76 | 0.568 |
| TAS (μmol Trolox Eq/mg) | 0.54±0.37 | 0.33±0.23 | 0.46±0.35 | 0.33±0.1 | 0.25±0.02 | 0.258 |
| TOS (nmol H2O2 Eq/mg) | 2.22±2.24 | 1.78±2.3 | 5.39±8.87 | 3.22±1.89 | 0.93±0.67 | 0.117 |
| Arylesterase (U/mg) | 590.8±117.13 | 692.27±251.58 | 541.07±291.24 | 637.47±258.54 | 737.4±76.91 | 0.516 |
| Catalase (mU/mg) | 200.93±170.43 | 210.49±103.99 | 146.85±71.91 | 174.6±69.5 | 193.93±35.25 | 0.495 |
| AOPP (nmol chloramine-T Eq/mg) | 122.37±105.85 | 60.06±53.27 | 97±128.6 | 54.76±23.37 | 56.82±30.04 | 0.261 |
| Myeloperoxidase (mU/mg) | 19.18±17.15 | 30.91±28.24 | 38.18±50.33 | 48.01±47 | 31.01±37.13 | 0.566 |
Coefficient (r) and significance of the correlation between the tissue and serum parameters.
| Tissue parameters | Serum parameters | |||||||||||
| TAS | TOS | Paraoxonase | Stimulated paraoxonase | Arylesterase | Ceruloplasmin | Catalase | TTL | Myeloperoxidase | AOPP | IMA | ||
| Protein level | r | -0.105 | 0.078 | -0.280 | -0.272 | -0.113 | -0.019 | 0.129 | 0.070 | 0.063 | 0.030 | -0.015 |
| p | 0.405 | 0.536 | 0.370 | 0.878 | 0.307 | 0.580 | 0.619 | 0.812 | 0.904 | |||
| TAS | r | 0.022 | -0.123 | 0.201 | 0.197 | -0.062 | -0.038 | -0.182 | -0.106 | 0.101 | -0.133 | -0.137 |
| p | 0.864 | 0.328 | 0.108 | 0.116 | 0.621 | 0.762 | 0.148 | 0.399 | 0.422 | 0.293 | 0.278 | |
| TOS | r | -0.067 | -0.087 | 0.070 | 0.067 | 0.038 | -0.011 | -0.144 | -0.064 | -0.038 | -0.171 | -0.121 |
| p | 0.598 | 0.491 | 0.579 | 0.595 | 0.763 | 0.928 | 0.252 | 0.612 | 0.765 | 0.172 | 0.336 | |
| Arylesterase | r | 0.012 | 0.009 | 0.059 | 0.060 | 0.036 | 0.040 | 0.024 | -0.011 | -0.026 | 0.065 | 0.072 |
| p | 0.923 | 0.942 | 0.643 | 0.638 | 0.779 | 0.753 | 0.847 | 0.929 | 0.835 | 0.608 | 0.568 | |
| Catalase | r | 0.025 | -0.062 | 0.027 | 0.019 | 0.082 | 0.068 | -0.020 | -0.070 | -0.130 | 0.077 | -0.008 |
| p | 0.842 | 0.625 | 0.832 | 0.878 | 0.514 | 0.592 | 0.872 | 0.578 | 0.303 | 0.541 | 0.951 | |
| AOPP | r | 0.039 | -0.115 | 0.187 | 0.179 | 0.043 | 0.034 | -0.186 | -0.134 | -0.017 | -0.165 | -0.074 |
| p | 0.761 | 0.364 | 0.135 | 0.154 | 0.734 | 0.786 | 0.138 | 0.288 | 0.891 | 0.189 | 0.556 | |
| Myeloperoxidase | r | 0.011 | 0.046 | -0.010 | -0.006 | -0.005 | -0.147 | 0.105 | 0.070 | -0.069 | 0.024 | -0.130 |
| p | 0.933 | 0.716 | 0.938 | 0.959 | 0.970 | 0.242 | 0.405 | 0.581 | 0.587 | 0.851 | 0.302 | |